Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(100.0%)
1Total
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06101459Not Yet Recruiting

A Study About Association Between Microbiome, Metabolome and Clinical Characteristics in COPD Patients

Role: collaborator

NCT05527301Phase 2Unknown

HEM1036 Phase 2 Study in Low Anterior Resection Syndrome

Role: lead

NCT05659277Unknown

The Effects of Stress & Irregular Shift Hours on First Responders

Role: collaborator

NCT05388630Unknown

Microbiome, Anxiety and Cognitive Orientation Study

Role: collaborator

All 4 trials loaded